Insulin-like growth factors control the regulation of oestrogen and progesterone receptor expression by oestrogens

Molecular and Cellular Endocrinology

Volumn 128, Issue 1-2, 1997, Pages 57-68

  Clayton, Simon J ^a   May, Felicity E B ^a   Westley, Bruce R ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Antiestrogen; Breast cancer; Estrogen; Insulin; Insulin like growth factor; Type I insulin like growth factor receptor

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; LIGAND; MESSENGER RNA; PROGESTERONE RECEPTOR; SOMATOMEDIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

BREAST NEOPLASMS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KINETICS; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TAMOXIFEN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030933725     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)04016-6     Document Type: Article

References (68)

1. Ottaviano, Y.L., Issa, J.P., Pari, F.F., Smith, H.S., Baylin, S.B. and Davidson, N.E. (1994) Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 54, 2552-2555.
2. Westley, B.R. and Knowland, J. (1979) Oestrogen causes a rapid, large, and prolonged rise in the level of nuclear estrogen receptor in Xenopus laevis liver. Biochim. Biophys. Res. Commun. 88, 1167-1172.
3. Scheider, W. and Gschwent, M. (1977) Kinetics of the appearance of nuclear estrogen binding sites in chicken liver. Hoppe-Seyler's Z. Physiol. Chem. 358, 1583-1592.
4. Smith, J.S. and Thomas, P. (1991) Changes in hepatic estrogen-receptor concentrations during the annual reproductive and ovarian cycles of a marine teleost, the spotted seatrout, Cynoscion nebulosus. Gen. Comp. Endocrinol. 81, 234-245.
5. Saceda, M., Lippman, M.E., Lindsey, R.K., Puente, M. and Martin, M.B. (1989) Role of an estrogen receptor-dependent mechanism in the regulation of the estrogen receptor mRNA in MCF-7 cells. Mol. Endocrinol. 3, 1782-1787.
6. Welshons, W.V. and Jordan, V.C. (1987) Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur. J. Cancer 23, 1935-1939.
7. Pink, J.J. and Jordan, V.C. (1996) Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res. 56, 2321-2330.
8. Katzenellenbogen, B.S. (1996) Estrogen receptors: Bioactivities and interactions with cell signalling pathways. Biol. Reprod. 54, 287-293.
9. Stewart, A.J., Johnson, M.D., May, F.E.B. and Westley, B.R. (1990) Role of IGFs and the type IIGF receptor in the estrogen stimulated proliferation of human breast cancer cells. J. Biol. Chem. 265, 21 172-21 178.
10. Thorsen, T., Lahooti, H., Rasmussen, M. and Aakvaag, A. (1992) Estradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effects of IGF-I. J Steroid Biochem. Mol. Biol. 41, 537-540.
11. Van Der Burg, B., Rutteman, G.R., Blankenstein, M.A., De Laat, S.W. and Van Zoelen, E.J.J. (1988) Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: Synergistic action of insulin and estrogen. J. Cell Physiol. 134, 101-108.
12. Surmacz, E. and Burgaud, J.-L. (1995) Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation. Clin. Cancer Res. 1, 1429-1436.
13. Daws, M.R., Westley, B.R. and May, F.E.B. (1996) Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol. Endocrinology 137, 1177-1186.
14. Yee, D., Cullen, K.J., Paik, S., Perdue, J.F., Lippman, M.E. and Rosen, N. (1988) Insulin-like growth factor II expression in human breast cancer. Cancer Res. 48, 6691-6696.
15. Osborne, C.K., Coronado, E.B., Kitten, L.J., Arteaga, C.L., Fuqua, S.A., Ramasharma, K., Marshall, M. and Li, C.H. (1989) Insulin-like growth factor II (IGF-II): a potential autocrine paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol. 3, 1701-1709.
16. Clemmons, D.R., Camacho-Hubner, C., Coronado, E. and Osborne, C.K. (1990) Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 127, 2679-2686.
17. Sheikh, M.S., Shao, Z.-M., Hussain, A., Chen, J.-C., Roberts, C.T., LeRoith, D. and Fontana, J.A. (1993) Retinoic acid and estrogen modulation of insulin-like growth factor binding protein-4 gene expression and the estrogen receptor status of human breast carcinoma cells. Biochem. Biophys. Res. Commun. 193, 1232-1238.
18. Furr, B.J.A. and Jordan, V.C. (1984) The pharmacology and clinical uses of tamoxifen. Pharm. Ther. 25, 127-205.
19. DeFriend, D.J., Howell, A., Nicholson, R.I., Anderson, E., Dowsett, M., Mansel, R.E., Blamey, R.W., Bundred, N.J., Robertson, J.F., Saunders, C., Baum, M., Walton, P., Sutcliffe, F. and Wakeling, A.E. (1994) Investigation of a new pure antiestrogen (ICI 182,780) in women with primary breast cancer. Cancer Res. 54, 408-414.
20. Fujimoto, N. and Katzenellenbogen, B.S. (1994) Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signalling pathways in breast cancer cells: Antiestrogen selectivity and promoter dependence. Mol. Endocrinol. 8, 296-304.
21. May, F.E.B. and Westley, B.R. (1988) Identification and characterisation of estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 263, 12901-12908.
22. Johnson, M.D., Westley, B.R. and May, F.E.B. (1989) Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells. Br. J. Cancer 59, 727-738.
23. Auffray, C. and Rougeon, F. (1980) Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107, 303-314.
24. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P. and Chambon, P. (1986) Human oestrogen receptor cDNA: sequence expression and homology to v-erb-A. Nature 320, 134-139.
25. Al Saati, Clamens, S., Cohenknafo, E., Faye, J.C., Prats, H., Coindre, J.M., Wafflart. J., Caveriviere, P., Bayard, F. and Delsol, G. (1993) Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int. J. Cancer 55, 651-654.
26. May, F.E.B., Johnson, M.D., Wiseman, L.R., Wakeling, A.E., Kastner, P. and Westley, B.R. (1989) Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines. J. Steroid. Biochem. 33, 1035-1041.
27. Swaneck, G.E. and Fishman, J. (1991) Effects of estrogens on MCF-7 cells: positive or negative regulation by the nature of the ligand receptor complex Biochem. Biophys. Res. Comm. 174,276-281.
28. Murayama, Y., Kurata, S. and Mishim, Y. (1988) Regulation of the human estrogen receptor gene, epidermal growth factor receptor gene and oncogenes by estrogen and antiestrogen in MCF-7 breast cancer cells. Cancer Detect. Preven. 13, 103-107.
29. Ree, A.M., Landmark, B.F., Eskild, W., Levy, F.O., Lahooti, H., Jahnsen, T., Aakvaag. A. and Hansson, V. (1989) Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: and inverse correlation to progesterone receptor levels. Endocrinology 124, 2577-2583.
30. Read, L.D., Greene, G.L. and Katzenellenbogen, B.S. (1989) Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists and growth factors. Mol. Endocrinol. 3, 295-304.
31. Westley, B.R. and May, F.E.B. (1988) Oestrogen regulates oestrogen receptor mRNA levels in an oestrogen-responsive human breast cancer cell line. Biochem. Biophys. Res. Comm. 155, 1113-1118.
32. ∞ and MCF-7 breast cancer cells. Mol. Endocrinol. 3, 22-28.
33. Murphy, C., Meisner, L., Wu, S,Q, and Jordan, V.C. (1989) Short- and long-term estrogen deprivation of T47D human breast cancer cells in culture. Eur. J. Cancer 25, 1777-1788.
34. Daly, R.J. and Darbre, P.D. (1990) Cellular and molecular events in loss of estrogen sensitivity in ZR75-1 and T47D human breast cancer cells. Cancer Res. 50, 5868-5875.
35. Webb, P., Lopex, G.N., Greene, G.L., Baxter, J.D. and Kushner, P.J. (1992) The limits of the cellular capacity to mediate an estrogen response. Mol. Endocrinol. 6, 157-167.
36. Corthesy, B., Claret, F.X. and Wahli, W. (1990) Estrogen receptor level determines sex-specific in vitro transcription from the Xenopus vitellogenin promoters. Proc. Natl. Acad. Sci. USA. 87, 7878-7882.
37. Boyd, M.T., Hildebrandt, R.H. and Bartow, S.A. (1996) Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Res. Treat. 37, 243-251.
38. Battersby, S., Robertson, B.J., Anderson, T.J., King, R.J.B. and McPherson, K. (1992) Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br. J. Cancer 65, 601-607.
39. Williams, G., Anderson, E., Howell, A., Watson, R., Coyne, J., Roberts, S.A. and Potten, C.S. (1991) Oral contraceptive (OCP) use increases proliferation and decreases estrogen receptor content of epithelial cells in the normal human breast. Int. J. Cancer 48, 206-210.
40. Malet, C., Gompel, A., Yaneva, H., Cren, H., Fidji, N., Mowszowicz, I., Kuttenn, F. and Mauvais-Jarvis, P. (1991) Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. J. Endocrinol. Met. 73, 8-17.
41. Mauvais-Jarvis, P., Kuttenn, F., Malet, C. and Gompel, A. (1990). Ann. NY Acad. Sci. 595, 409.
42. Grandien, K., Backdahl, M., Ljunggren, O., Gustafsson, J.-A. and Berkenstam, A. (1995) Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumour cell lines. Endocrinology 136, 2223-2229.
43. Grandien, K. (1996) Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol. Cell. Endocrinol. 116, 207-212.
44. Weigel, R.J., Crooks, D.L., Iglehart, D. and deConinck, E.C. (1995) Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma. Cell Growth Differ. 6, 707-711.
45. Piva, R., Bianchi, N., Aguiari, G.L., Gambari, R. and Del Senno, L. (1993) Sequencing of an RNA transcript of the human estrogen receptor gene: evidence for a new transcriptional event. J. Steroid Biochem. Mol. Biol. 46, 531-538.
46. Kaneko, K.J., Furlow, J.D. and Gorski, J. (1993) Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol. Endocrinol. 7, 879-888.
47. Lee, J.H., Kim, J. and Shapiro, D.J. (1995) Regulation of Xenopus laevis estrogen receptor gene expression is mediated by an estrogen response element in the protein coding region. DNA Cell Biol. 14, 419-430.
48. Le Dréan, Y., Lazennec, G., Kern, L., Saligaut, D., Pakdel, F. and Valotaire, Y. (1995) Characterization of an estrogen-responsive element implicated in regulation of the rainbow trout estrogen receptor gene. J. Mol. Endocrinol. 15, 37-47.
49. Keaveney, M., Parker, M.G. and Gannon, F. (1993) Identification of a functional role for the 3' region of the human oestrogen receptor gene. J. Mol. Endocrinol. 10, 143-152.
50. Granner, D.K. (1987) The molecular biology of insulin action on protein synthesis. Kidney Int. 32, S82-S93.
51. Cormier, E.M., Wolf, M.F. and Jordan, V.C. (1989) Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth. Cancer Res. 49, 576-580.
52. Ignar-Trowbridge, D.M., Pimentel, M., Parker, M.G., McLachlan, J.A. and Korach, K.S. (1996) Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or receptor. Endocrinology 137, 1735-1744.
53. Le Goff, P., Montano, M.M., Schodin, D.J. and Katzenellenbogen, B.S. (1994) Phosphorylation of the estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269, 4458-4466.
54. Lahooti, H., White, R., Hoare, S.A., Rahman, D., Pappin, D.J.C. and Parker, M.G. (1995) Identification of phosphorylation sites in the mouse oestrogen receptor. J. Steroid Biochem. Mol. Biol. 55, 305-313.
55. May, F.E.B. and Westley, B.R. (1987) Effects of tamoxifen and 4'-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 263, 12 901-12 908.
56. Lees, J.A., Fawell, S.E. and Parker, M.G. (1989) Identification of constitutive and steroid-dependent transactivation domains in the mouse estrogen receptor. J. Steroid Biochem. 34, 33-39.
57. Wakeling, A.E. (1995) Use of pure antioestrogens to elucidate the mode of action of oestrogens. Biochem. Pharmacol. 49, 1545-1549.
58. Wiseman, L.R., Wakeling, A.E., May, F.E.B. and Westley, B.R. (1989) The effects of the antioestrogen ICI 164,384 on oestrogen induced RNAs in MCF-7 cells J. Steroid Biochem. 33, 1-6.
59. Weaver, C.A., Springer, P.A., Chambon, P. and Katzenellenbogen, B.S. (1988) Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens; comparison of effects on the native gene and on pS2-chloramphenicol acetyl transferase fusion genes transfected into MCF-7 human breast cancer cells. Mol. Endocrinol. 2, 936-945.
60. Ince, B.A., Montano, M.M. and Katzenellenbogen, B.S. (1994) Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens. Mol. Endocrinol. 8, 1397-1406.
61. Mahfoudi, A., Roulet, E., Dauvois, S., Parker, M.G. and Wahli, W. (1995) Specific mutations in the estrogen receptor change the properties of antiestrogens from antiestrogens to full agonists. Proc. Natl. Acad. Sci. USA. 92, 4206-4210.
62. Dauvois, S., Danielian, P.S., White, R. and Parker, M.G. (1992) Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA. 89, 4037-4041.
63. Dauvois, S., White, R. and Parker, M. (1993) The antiestrogen ICI 182,780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell Sci. 106, 1377-1388.
64. Vanderbilt, J.N., Miesfeld, R., Maler, B.A. and Yamomoto, K.R. (1987) Intracellular receptor concentration limits glucocorticoid dependent enhancer activity. Mol. Endocrinol. 1, 68-74.
65. Katzenellenbogen, B.S. and Norman, M.J. (1990) Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells. Interrelationships among insulin/insulin-like growth factor-I, serum and estrogen. Endocrinology 126, 891-898.
66. Cho, H., Aronica, S.M. and Katzenellenbogen, B.S. (1994) Regulation of progesterone receptor gene expression: a comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin-like growth factor-1 and serum factors. Endocrinology 134, 658-664.
67. Noguchi, S., Motomura, K., Inaji, H., Imaoka, S. and Koyama, H. (1993) Up-regulation of estrogen receptor by tamoxifen in human breast cancer. Cancer 71, 1266-1272.
68. McClelland, R.A., Manning, D.L., Gee, J.M.W., Anderson, E., Clarke, R., Howell, A., Dowsett, M., Robertson, J.F.R., Blamey, R.W., Wakeling, A.E. and Nicholson, R.I. (1996) Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes. Breast Cancer Res. Treat. (In Press).